The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Hepatitis C Remains Major Problem for HIV Patients Despite Antiretroviral Therapy

March 18, 2014

This article was reported by Infection Control Today.

Infection Control Today reported that the risk of serious liver disease from hepatitis C virus (HCV) infection is high for HCV/HIV-coinfected patients, regardless of whether they receive antiretroviral therapy (ART). To investigate whether ART slows liver fibrosis connected with HCV, researchers from the Perelman School of Medicine at the University of Pennsylvania (UPenn) reviewed electronic medical records of 4,280 HCV/HIV-coinfected patients who were receiving ART, and 6,079 HCV-only patients treated from 1997 through 2010.

Liver disease presents in two stages: compensated, when the liver can function normally by compensating for damage; and decompensated, when the liver can no longer function normally due to widespread damage. Findings indicated that the coinfected patients had an 80-percent higher rate of decompensated cirrhosis than patients with HCV only. When ART controlled the HIV in coinfected patients, they experienced a 60-percent higher rate of serious liver disease than patients with HCV only. Also, decompensation rates were higher for coinfected patients with advanced liver fibrosis, severe

View Full Article

  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

See Also
Talk to a Physician About HIV/Hepatitis Coinfection in Our "Ask the Experts" Forums
More News on Hepatitis C Transmission

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining: